Mural Oncology PLC (MURA)
3.78
-0.11
(-2.83%)
USD |
NASDAQ |
May 20, 15:35
Mural Oncology Cash from Operations (Quarterly): -37.34M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -37.34M |
December 31, 2023 | -42.72M |
September 30, 2023 | -50.47M |
Date | Value |
---|---|
June 30, 2023 | -45.32M |
March 31, 2023 | -55.74M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-55.74M
Minimum
Mar 2023
-37.34M
Maximum
Mar 2024
-46.32M
Average
-45.32M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
Amarin Corp PLC | -12.60M |
Jazz Pharmaceuticals PLC | 267.23M |
Prothena Corp PLC | -73.05M |
Iterum Therapeutics PLC | -13.08M |
GH Research PLC | -9.596M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -124.54M |
Free Cash Flow | -178.96M |
Free Cash Flow Per Share (Quarterly) | -2.227 |
Free Cash Flow Yield | -283.2% |